
G2b Biologics Private Limited
About G2b Biologics Private Limited
Data last updated:
G2b Biologics Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 13 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73200PN2018PTC175351. Its GSTIN is 27AAHCG2227P1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sureshkumar Ramasamy and Deepanjan Ghosh.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No 12 Sr No 651/1 Aai Mata Mandir Road Near Datta Temple, Pune, Maharashtra, India – 411037.
As per the financials filed for FY 2021, the company reported a revenue of ₹13.56 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹93,696 (net margin -6.9%) and EBITDA of -₹92,722 (EBITDA margin -6.8%).
Company details
Recognitions & Rankings of G2b Biologics
Contact details
G2b Biologics Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 12 Sr No 651/1 Aai Mata Mandir Road Near Datta Temple, Pune, Maharashtra, India – 411037
- IndustryLife Sciences, Biotechnology
To see the full contact details of G2b Biologics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of G2b Biologics is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
Financials of G2b Biologics Private Limited
FY 2021 filings availableG2b Biologics Private Limited reported revenue of ₹13.56 Lakh (down 23% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹13.56 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹92,722 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹93,696 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6.8% | |||
| Net Profit Margin | -6.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of G2b Biologics Private Limited, buy the company report.
Board of directors of G2b Biologics Private Limited
G2b Biologics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sureshkumar Ramasamy | Director | 13 Mar 2018 | 8 Years 7 Months | Current |
| Deepanjan Ghosh | Director | 13 Mar 2018 | 8 Years 7 Months | Current |
Auditor
G2b Biologics Private Limited is audited by NALINI RAMASWAMY & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NALINI RAMASWAMY & CO | FY 2021 | 114436W |
Shareholding
The shareholding of G2b Biologics Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of G2b Biologics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving G2b Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G2b Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
G2b Biologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG2227P1Z9 | Maharashtra | Active | 12 Sep 2019 |
To see the full GST registrations and return filing status of G2b Biologics Private Limited, buy the company report.
Recent activity
G2b Biologics Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Harshavardhan Thirupathi ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
G2b Biologics is an active private limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 13 March 2018 (8+ years old) and is registered under CIN U73200PN2018PTC175351.
G2b Biologics has 2 current directors:
- Sureshkumar Ramasamy - Director
- Deepanjan Ghosh - Director
The latest financial statements of G2b Biologics on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2018 are in the company report.
The GSTIN of G2b Biologics is 27AAHCG2227P1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of G2b Biologics is U73200PN2018PTC175351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G2b Biologics was incorporated on 13 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Harshavardhan Thirupathi ceased to be Additional Director on 30 Sep 2019. Deepanjan Ghosh was appointed as Director on 13 Mar 2018. Sureshkumar Ramasamy was appointed as Director on 13 Mar 2018.
Yes, G2b Biologics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of G2b Biologics is at Plot No 12 Sr No 6511 Aai Mata Mandir Road Near Datta Temple, Pune, Maharashtra, India – 411037.
G2b Biologics operates in the life sciences industry, in the biotechnology segment.

